ID

12993

Beskrivning

A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00001384

Länk

https://clinicaltrials.gov/show/NCT00001384

Nyckelord

  1. 2016-01-10 2016-01-10 -
Uppladdad den

10 januari 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Breast Cancer NCT00001384

Eligibility Breast Cancer NCT00001384

Criteria
Beskrivning

Criteria

patients will be eligible for study either before or after receiving adjuvant radiation therapy.
Beskrivning

adjuvant radiation therapy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C1522673
patients with stage iii disease will be eligible to receive this regimen as neo-adjuvant chemotherapy or as adjuvant therapy if surgery was performed prior to patient referral.
Beskrivning

chemotherapy, surgery

Datatyp

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0038894
patients must be previously untreated with chemotherapy.
Beskrivning

chemotherapy

Datatyp

boolean

Alias
UMLS CUI [1]
C0392920
there must be no history of previous malignancy except for cured non-melanoma skin cancer (basal or squamous cell carcinoma), cervical cancer in situ, or a past malignancy that has been inactive for over 5 years. patients with a prior history of lower stage contralateral breast cancer, treated with surgery, and/or radiation, but not chemotherapy, are eligible for this study.
Beskrivning

malignancies

Datatyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0553723
UMLS CUI [4]
C0007847
UMLS CUI [5,1]
C0006142
UMLS CUI [5,2]
C0441988
performance status (karnofsky scale) must be greater than 70; ecog 0 to 2.
Beskrivning

karnofsky, ecog

Datatyp

boolean

Alias
UMLS CUI [1]
C0206065
UMLS CUI [2]
C1520224
absolute granulocyte count greater than 1500 per microliter and platelet count greater than 100,000 per mm(3).
Beskrivning

granulocyte count, platelet count

Datatyp

boolean

Alias
UMLS CUI [1]
C0857490
UMLS CUI [2]
C0005821
liver function tests (sgot, and total bilirubin) should be less than 2x upper limits of normal. serum creatinine should be less than 1.7 or creatinine clearance should be greater than 45 ml per min.
Beskrivning

liver function, renal function

Datatyp

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201976
UMLS CUI [4]
C0373595
the patient must be able to give an informed consent, and to return to nci for treatment and adequate follow-up for the period the protocol requires.
Beskrivning

informed consent, follow up

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C1522577
patients must be greater than or equal to 18 years of age.
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
patients and/or their partners must be willing to practice a non-hormonal method of contraception during therapy and for 6 months following therapy.
Beskrivning

contraception

Datatyp

boolean

Alias
UMLS CUI [1]
C0700589
patients who are poor medical or psychiatric risks because of nonmalignant systemic disease which would preclude them from being subjected to any treatments in this protocol are excluded.
Beskrivning

comorbidities, compliance

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
patients must have a normal ejection fraction by muga scan and have no angina. patients should not currently require therapy for cardiac arrhythmias, congestive heart failure, or coronary artery disease.
Beskrivning

heart function, heart diseases

Datatyp

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0232164
no patients with a history of symptomatic cns disease.
Beskrivning

CNS disease

Datatyp

boolean

Alias
UMLS CUI [1]
C0007682
no patients with allergy to any study medication.
Beskrivning

Allergy to protocol agent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1521826
no pregnant or lactating women.
Beskrivning

pregnant or lactating

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C2828358
patients with bleeding disorders are ineligible for study entry as are patients requiring chronic anticoagulation.
Beskrivning

bleeding disorders, anticoagulation

Datatyp

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2]
C0003280

Similar models

Eligibility Breast Cancer NCT00001384

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
adjuvant radiation therapy
Item
patients will be eligible for study either before or after receiving adjuvant radiation therapy.
boolean
C1522449 (UMLS CUI [1,1])
C1522673 (UMLS CUI [1,2])
chemotherapy, surgery
Item
patients with stage iii disease will be eligible to receive this regimen as neo-adjuvant chemotherapy or as adjuvant therapy if surgery was performed prior to patient referral.
boolean
C0392920 (UMLS CUI [1])
C0038894 (UMLS CUI [2])
chemotherapy
Item
patients must be previously untreated with chemotherapy.
boolean
C0392920 (UMLS CUI [1])
malignancies
Item
there must be no history of previous malignancy except for cured non-melanoma skin cancer (basal or squamous cell carcinoma), cervical cancer in situ, or a past malignancy that has been inactive for over 5 years. patients with a prior history of lower stage contralateral breast cancer, treated with surgery, and/or radiation, but not chemotherapy, are eligible for this study.
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
C0007847 (UMLS CUI [4])
C0006142 (UMLS CUI [5,1])
C0441988 (UMLS CUI [5,2])
karnofsky, ecog
Item
performance status (karnofsky scale) must be greater than 70; ecog 0 to 2.
boolean
C0206065 (UMLS CUI [1])
C1520224 (UMLS CUI [2])
granulocyte count, platelet count
Item
absolute granulocyte count greater than 1500 per microliter and platelet count greater than 100,000 per mm(3).
boolean
C0857490 (UMLS CUI [1])
C0005821 (UMLS CUI [2])
liver function, renal function
Item
liver function tests (sgot, and total bilirubin) should be less than 2x upper limits of normal. serum creatinine should be less than 1.7 or creatinine clearance should be greater than 45 ml per min.
boolean
C0201899 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0373595 (UMLS CUI [4])
informed consent, follow up
Item
the patient must be able to give an informed consent, and to return to nci for treatment and adequate follow-up for the period the protocol requires.
boolean
C0021430 (UMLS CUI [1])
C1522577 (UMLS CUI [2])
Age
Item
patients must be greater than or equal to 18 years of age.
boolean
C0001779 (UMLS CUI [1])
contraception
Item
patients and/or their partners must be willing to practice a non-hormonal method of contraception during therapy and for 6 months following therapy.
boolean
C0700589 (UMLS CUI [1])
comorbidities, compliance
Item
patients who are poor medical or psychiatric risks because of nonmalignant systemic disease which would preclude them from being subjected to any treatments in this protocol are excluded.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
heart function, heart diseases
Item
patients must have a normal ejection fraction by muga scan and have no angina. patients should not currently require therapy for cardiac arrhythmias, congestive heart failure, or coronary artery disease.
boolean
C0018799 (UMLS CUI [1])
C0232164 (UMLS CUI [2])
CNS disease
Item
no patients with a history of symptomatic cns disease.
boolean
C0007682 (UMLS CUI [1])
Allergy to protocol agent
Item
no patients with allergy to any study medication.
boolean
C0020517 (UMLS CUI [1,1])
C1521826 (UMLS CUI [1,2])
pregnant or lactating
Item
no pregnant or lactating women.
boolean
C0032961 (UMLS CUI [1])
C2828358 (UMLS CUI [2])
bleeding disorders, anticoagulation
Item
patients with bleeding disorders are ineligible for study entry as are patients requiring chronic anticoagulation.
boolean
C0005779 (UMLS CUI [1])
C0003280 (UMLS CUI [2])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial